Direxion Daily S&P Biotech Bear 3X ETF
Usually, when investors add biotechnology stocks to their portfolios, they feel confident about risk. Often this risk-on mentality pushes risky, binary names up and up.
Biotech stocks—with their binary outcomes and potential FDA approvals or denials—should whip around, pending various outcomes.
Donald Trump wants to repeal the Affordable Care Act (or ACA) and replace it with a new act that encourages free-market competition.
Company & Industry Overviews
When Republican George H.W. Bush was elected president, the S&P 500 rose 8.5% three months after the election. It had a return of 11.2% six months after the election.